Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 259

1.

Gastrointestinal polyposis syndromes for the general gastroenterologist.

Hurley JJ, Ewing I, Sampson JR, Dolwani S.

Frontline Gastroenterol. 2014 Jan;5(1):68-76. doi: 10.1136/flgastro-2013-100327. Epub 2013 Jun 14.

2.

Management of desmoid tumours: A large national database of familial adenomatous patients shows a link to colectomy modalities and low efficacy of medical treatments.

Walter T, Zhenzhen Wang C, Guillaud O, Cotte E, Pasquer A, Vinet O, Poncet G, Ponchon T, Saurin JC.

United European Gastroenterol J. 2017 Aug;5(5):735-741. doi: 10.1177/2050640616678150. Epub 2016 Oct 28.

3.

Attenuated adenomatous polyposis of the large bowel: Present and future.

Roncucci L, Pedroni M, Mariani F.

World J Gastroenterol. 2017 Jun 21;23(23):4135-4139. doi: 10.3748/wjg.v23.i23.4135.

4.

A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors.

Dumanski JP, Rasi C, Björklund P, Davies H, Ali AS, Grönberg M, Welin S, Sorbye H, Grønbæk H, Cunningham JL, Forsberg LA, Lind L, Ingelsson E, Stålberg P, Hellman P, Tiensuu Janson E.

Endocr Relat Cancer. 2017 Aug;24(8):427-443. doi: 10.1530/ERC-17-0196. Epub 2017 Jun 20.

5.

8-Oxo-7,8-dihydroguanine, friend and foe: Epigenetic-like regulator versus initiator of mutagenesis.

Fleming AM, Burrows CJ.

DNA Repair (Amst). 2017 Aug;56:75-83. doi: 10.1016/j.dnarep.2017.06.009. Epub 2017 Jun 9. Review.

PMID:
28629775
6.

A Specific Mutational Signature Associated with DNA 8-Oxoguanine Persistence in MUTYH-defective Colorectal Cancer.

Viel A, Bruselles A, Meccia E, Fornasarig M, Quaia M, Canzonieri V, Policicchio E, Urso ED, Agostini M, Genuardi M, Lucci-Cordisco E, Venesio T, Martayan A, Diodoro MG, Sanchez-Mete L, Stigliano V, Mazzei F, Grasso F, Giuliani A, Baiocchi M, Maestro R, Giannini G, Tartaglia M, Alexandrov LB, Bignami M.

EBioMedicine. 2017 Jun;20:39-49. doi: 10.1016/j.ebiom.2017.04.022. Epub 2017 Apr 13.

7.

Exploratory plasma proteomic analysis in a randomized crossover trial of aspirin among healthy men and women.

Wang X, Shojaie A, Zhang Y, Shelley D, Lampe PD, Levy L, Peters U, Potter JD, White E, Lampe JW.

PLoS One. 2017 May 25;12(5):e0178444. doi: 10.1371/journal.pone.0178444. eCollection 2017.

8.

Gastrointestinal tract cancers: Genetics, heritability and germ line mutations.

Lv XP.

Oncol Lett. 2017 Mar;13(3):1499-1508. doi: 10.3892/ol.2017.5629. Epub 2017 Jan 20.

9.

A molecular inversion probe-based next-generation sequencing panel to detect germline mutations in Chinese early-onset colorectal cancer patients.

Zhang J, Wang X, de Voer RM, Hehir-Kwa JY, Kamping EJ, Weren RDA, Nelen M, Hoischen A, Ligtenberg MJL, Hoogerbrugge N, Yang X, Yang Z, Fan X, Wang L, Liu H, Wang J, Kuiper RP, van Kessel AG.

Oncotarget. 2017 Apr 11;8(15):24533-24547. doi: 10.18632/oncotarget.15593.

10.

Molecular genetics of microsatellite-unstable colorectal cancer for pathologists.

Chen W, Swanson BJ, Frankel WL.

Diagn Pathol. 2017 Mar 4;12(1):24. doi: 10.1186/s13000-017-0613-8. Review.

11.

Oxidative DNA damage induces hypomethylation in a compromised base excision repair colorectal tumourigenesis.

Furlan D, Trapani D, Berrino E, Debernardi C, Panero M, Libera L, Sahnane N, Riva C, Tibiletti MG, Sessa F, Sapino A, Venesio T.

Br J Cancer. 2017 Mar 14;116(6):793-801. doi: 10.1038/bjc.2017.9. Epub 2017 Jan 31.

PMID:
28141798
12.

Structural Basis for the Lesion-scanning Mechanism of the MutY DNA Glycosylase.

Wang L, Chakravarthy S, Verdine GL.

J Biol Chem. 2017 Mar 24;292(12):5007-5017. doi: 10.1074/jbc.M116.757039. Epub 2017 Jan 27.

PMID:
28130451
13.

Repair of 8-oxoG:A mismatches by the MUTYH glycosylase: Mechanism, metals and medicine.

Banda DM, Nuñez NN, Burnside MA, Bradshaw KM, David SS.

Free Radic Biol Med. 2017 Jun;107:202-215. doi: 10.1016/j.freeradbiomed.2017.01.008. Epub 2017 Jan 10. Review.

PMID:
28087410
14.

Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer.

Win AK, Jenkins MA, Dowty JG, Antoniou AC, Lee A, Giles GG, Buchanan DD, Clendenning M, Rosty C, Ahnen DJ, Thibodeau SN, Casey G, Gallinger S, Le Marchand L, Haile RW, Potter JD, Zheng Y, Lindor NM, Newcomb PA, Hopper JL, MacInnis RJ.

Cancer Epidemiol Biomarkers Prev. 2017 Mar;26(3):404-412. doi: 10.1158/1055-9965.EPI-16-0693. Epub 2016 Oct 31.

15.

Celecoxib and 2,5-dimethylcelecoxib inhibit intestinal cancer growth by suppressing the Wnt/β-catenin signaling pathway.

Egashira I, Takahashi-Yanaga F, Nishida R, Arioka M, Igawa K, Tomooka K, Nakatsu Y, Tsuzuki T, Nakabeppu Y, Kitazono T, Sasaguri T.

Cancer Sci. 2017 Jan;108(1):108-115. doi: 10.1111/cas.13106. Epub 2016 Dec 1.

16.

Translesion Synthesis of 2'-Deoxyguanosine Lesions by Eukaryotic DNA Polymerases.

Basu AK, Pande P, Bose A.

Chem Res Toxicol. 2017 Jan 17;30(1):61-72. doi: 10.1021/acs.chemrestox.6b00285. Epub 2016 Nov 1.

17.

MUTYH promotes oxidative microglial activation and inherited retinal degeneration.

Nakatake S, Murakami Y, Ikeda Y, Morioka N, Tachibana T, Fujiwara K, Yoshida N, Notomi S, Hisatomi T, Yoshida S, Ishibashi T, Nakabeppu Y, Sonoda KH.

JCI Insight. 2016 Sep 22;1(15):e87781.

18.

Letters.

[No authors listed]

Ulster Med J. 2016 Sep;85(3):203-210. No abstract available.

19.

Familial Colorectal Cancer: Understanding the Alphabet Soup.

Giglia MD, Chu DI.

Clin Colon Rectal Surg. 2016 Sep;29(3):185-95. doi: 10.1055/s-0036-1584290. Review.

20.

A novel germline POLE mutation causes an early onset cancer prone syndrome mimicking constitutional mismatch repair deficiency.

Wimmer K, Beilken A, Nustede R, Ripperger T, Lamottke B, Ure B, Steinmann D, Reineke-Plaass T, Lehmann U, Zschocke J, Valle L, Fauth C, Kratz CP.

Fam Cancer. 2017 Jan;16(1):67-71. doi: 10.1007/s10689-016-9925-1.

Supplemental Content

Support Center